Therefore, D1R agonists are used to improving cognitive impairment, such as the development of agonists for functionally selective D1 ligands and positive allosteric modulators of D1R (Arnsten et al., 2017; Desai et al., 2021; Abi-Dargham et al., 2022). This evidence concerns the gene DRD1 and Cognitive impairment.